Standard

Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper. / Belenkaya, Svetlana V.; Merkuleva, Iuliia A.; Yarovaya, Olga I. и др.

в: Frontiers in Bioengineering and Biotechnology, Том 11, 1294266, 2023.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Belenkaya, SV, Merkuleva, IA, Yarovaya, OI, Chirkova, VY, Sharlaeva, EA, Shanshin, DV, Volosnikova, EA, Vatsadze, SZ, Khvostov, MV, Salakhutdinov, NF & Shcherbakov, D 2023, 'Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper', Frontiers in Bioengineering and Biotechnology, Том. 11, 1294266. https://doi.org/10.3389/fbioe.2023.1294266

APA

Belenkaya, S. V., Merkuleva, I. A., Yarovaya, O. I., Chirkova, V. Y., Sharlaeva, E. A., Shanshin, D. V., Volosnikova, E. A., Vatsadze, S. Z., Khvostov, M. V., Salakhutdinov, N. F., & Shcherbakov, D. (2023). Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper. Frontiers in Bioengineering and Biotechnology, 11, [1294266]. https://doi.org/10.3389/fbioe.2023.1294266

Vancouver

Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV и др. Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper. Frontiers in Bioengineering and Biotechnology. 2023;11:1294266. doi: 10.3389/fbioe.2023.1294266

Author

Belenkaya, Svetlana V. ; Merkuleva, Iuliia A. ; Yarovaya, Olga I. и др. / Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper. в: Frontiers in Bioengineering and Biotechnology. 2023 ; Том 11.

BibTeX

@article{a2ccd21d90e04efca48096af374cb61a,
title = "Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper",
abstract = "In the published article, there was an error in the Materials and methods section at the Paragraph 2.2. Plasmid name was displayed as “A commercially available plasmid pRK793 was used for TEV protease production”. The correct statement is “A self-made plasmid pET-TEV was used for TEV protease production”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",
author = "Belenkaya, {Svetlana V.} and Merkuleva, {Iuliia A.} and Yarovaya, {Olga I.} and Chirkova, {Varvara Yu} and Sharlaeva, {Elena A.} and Shanshin, {Daniil V.} and Volosnikova, {Ekaterina A.} and Vatsadze, {Sergey Z.} and Khvostov, {Mikhail V.} and Salakhutdinov, {Nariman F.} and Dmitriy Shcherbakov",
note = "Copyright {\textcopyright} 2023 Belenkaya, Merkuleva, Yarovaya, Chirkova, Sharlaeva, Shanshin, Volosnikova, Vatsadze, Khvostov, Salakhutdinov and Shcherbakov. Публикация для корректировки.",
year = "2023",
doi = "10.3389/fbioe.2023.1294266",
language = "English",
volume = "11",
journal = "Frontiers in Bioengineering and Biotechnology",
issn = "2296-4185",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper

AU - Belenkaya, Svetlana V.

AU - Merkuleva, Iuliia A.

AU - Yarovaya, Olga I.

AU - Chirkova, Varvara Yu

AU - Sharlaeva, Elena A.

AU - Shanshin, Daniil V.

AU - Volosnikova, Ekaterina A.

AU - Vatsadze, Sergey Z.

AU - Khvostov, Mikhail V.

AU - Salakhutdinov, Nariman F.

AU - Shcherbakov, Dmitriy

N1 - Copyright © 2023 Belenkaya, Merkuleva, Yarovaya, Chirkova, Sharlaeva, Shanshin, Volosnikova, Vatsadze, Khvostov, Salakhutdinov and Shcherbakov. Публикация для корректировки.

PY - 2023

Y1 - 2023

N2 - In the published article, there was an error in the Materials and methods section at the Paragraph 2.2. Plasmid name was displayed as “A commercially available plasmid pRK793 was used for TEV protease production”. The correct statement is “A self-made plasmid pET-TEV was used for TEV protease production”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the published article, there was an error in the Materials and methods section at the Paragraph 2.2. Plasmid name was displayed as “A commercially available plasmid pRK793 was used for TEV protease production”. The correct statement is “A self-made plasmid pET-TEV was used for TEV protease production”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85177475300&origin=inward&txGid=19bde74f1e2017025a5542cce9e917d4

UR - https://www.mendeley.com/catalogue/40bb1710-6071-355d-935f-035a7e11ca7d/

U2 - 10.3389/fbioe.2023.1294266

DO - 10.3389/fbioe.2023.1294266

M3 - Article

C2 - 38026885

VL - 11

JO - Frontiers in Bioengineering and Biotechnology

JF - Frontiers in Bioengineering and Biotechnology

SN - 2296-4185

M1 - 1294266

ER -

ID: 59234464